Restore Medical Solutions

Restore Medical Solutions is a medical‑device technology company that builds sterilization tray systems and related workflows to reduce handling and improve efficiency in surgical instrument reprocessing for hospitals, surgery centers and sterile processing departments. [2][1]

High-Level Overview

• Mission: Build systems that streamline surgical instrument sterilization and storage to raise efficiency and reduce touch‑points in the operating room → sterile processing workflow for hospitals and ambulatory surgical centers.[2][1]
  - Investment philosophy / Key sectors / Impact on startup ecosystem: Not applicable — Restore Medical Solutions is a portfolio/company (medical device) rather than an investment firm; it operates in the surgical/sterile‑processing device sector and influences hospital operational efficiency and sterile processing best practices by validating cost/benefit in clinical customers.[2][1]
  - What product it builds: Modular sterilization tray systems (Restore® and Restore iQ) designed to organize instruments, integrate with existing trays, and reduce reprocessing handling.[1][2]
  - Who it serves: Hospitals, surgical centers, sterile processing facilities and medical device manufacturers that reprocess reusable surgical instruments.[2]
  - What problem it solves: Reduces instrument touch‑points and misorganization during cleaning/sterilization, shortens sterile processing time, and helps ensure instruments are properly cleaned and tracked, producing measurable time and cost savings for sterile processing staff.[2]
  - Growth momentum: Founded in 2012, the company obtained 510(k) clearance (2013), ISO 13485 certification, patent protection, early commercial distribution and customer wins including academic hospitals (e.g., VCU, Duke) and a Series A funding round reported in 2012 — indicating early commercial traction and adoption in US hospitals.[1][2]

Origin Story

• Founding year and early evolution: Restore Medical Solutions was founded in 2012 and participated in the Memphis Bioworks Foundation’s ZeroTo510(k) accelerator as part of its early commercialization path.[2][1]
  - Founders and background / idea emergence: Public reporting identifies Steven King as CEO and Shawn Flynn as co‑founder and SVP of operations; the product idea emerged to address inefficiencies in instrument reprocessing and to create a tray system that reduces handling and improves cleaning/sterility outcomes.[2]
  - Early traction / pivotal moments: The company secured FDA 510(k) clearance in 2013, received ISO 13485 certification, was issued at least one patent, completed independent lab verification, closed a reported $2.5M Series A, and completed pilot/cost‑benefit trials with hospitals such as VCU that led to purchase orders and wider commercial distribution.[1][2]

Core Differentiators

• Product differentiators: Modular tray design (Restore® and Restore iQ) that can integrate into existing sterilization tray systems and is engineered to reduce instrument touch‑points and improve organization during reprocessing.[2][1]
  - Developer / user experience: Designed specifically for sterile processing workflows with a focus on time savings and ease of adoption (e.g., compatibility with existing trays and demonstrated cost‑benefit in hospital pilots).[2]
  - Speed, pricing, ease of use: Positioning and pilot results emphasize time savings for sterile processing staff and simple integration into current sterilization processes; specific pricing data is not reported in the sources reviewed.[2]
  - Track record & regulatory: Holds ISO 13485 certification, received FDA 510(k) clearance, and holds issued patent(s), supporting a regulated‑device commercial footprint.[1][2]

Role in the Broader Tech / Health‑Care Landscape

• Trend they are riding: Operational efficiency and safety in perioperative care, plus the broader move to systems that reduce manual handling and human error in reprocessing reusable medical devices.[2]
  - Why timing matters: Hospitals face continual pressure to reduce costs, improve turnover and maintain regulatory compliance for sterilization — solutions that demonstrably save staff time and improve process reliability fit current provider priorities.[2]
  - Market forces in their favor: Growing surgical volumes, heightened attention to instrument reprocessing quality, and hospital interest in cost‑of‑care reductions create demand for validated, easy‑to‑implement sterile processing innovations.[2]
  - Influence on the ecosystem: By piloting and validating cost‑benefit in academic hospitals and securing regulatory clearances, Restore Medical Solutions helps set practical standards and demonstrates ROI for device‑centric process improvements, encouraging adoption of similar sterile‑processing innovations across health systems.[2]

Quick Take & Future Outlook

• What’s next: Continued commercial expansion into more hospitals and surgery centers, broader adoption of Restore iQ modular trays, and further validation of cost/safety outcomes through additional pilots and customer contracts (sources indicate early hospital wins but provide no later‑stage financials).[2][1]
  - Trends that will shape them: Increased emphasis on perioperative efficiency, device reprocessing regulation, and hospital procurement focused on demonstrable ROI will drive demand for validated tray systems.[2]
  - How influence might evolve: If Restore consolidates clinical evidence of time/cost savings and scales distribution, it could become a standard component in sterile processing workflows and influence tray design expectations across the industry.[2]

Notes and limits: The available public records reviewed (company site and industry databases) focus on the company’s sterile‑processing tray products and early commercial/regulatory milestones from the 2012–2014 timeframe and list customers and pilot outcomes; I did not find recent (post‑2014) detailed financials or product roadmap disclosures in the sources provided, so statements about current scale and near‑term plans are inferred from earlier traction and should be validated with up‑to‑date company filings or direct contact.[1][2][4]